Direct-to-consumer pharmaceutical startup Hims & Hers Health said it is selling injectable GLP-1 weight loss drugs for a fraction of the cost of brand-name competitors such as Wegovy and Ozempic.

Pharmaceutical company Novo Nordisk is waiting on federal approval to sell its blockbuster GLP-1 weight-loss ... If approved, Wegovy’s pill form will hold 25-mg dose of the drug and be taken ...

CVS Caremark has selected Novo Nordisk’s Wegovy as the preferred GLP-1 medication for its largest ... The 7.5-milligram and 10-milligram single-dose vials are then sold for $599 and $699 ...

CVS Caremark to list Wegovy as preferred ... pay patients with access to all dose strengths of Wegovy in a high-quality pen. Price Action: NVO stock is down 1.78% at $65.27 at the last check ...

Novo Nordisk is partnering with online telehealth companies to sell a direct-to-consumer, lower cost version of its popular weight-loss drug Wegovy. The pharmaceutical company announced it would ...

Ascletis is taking a low and slow approach to oral GLP-1 dose titration in a phase 2a ... people in a third cohort that began on a 5-mg dose and then ramped up to 60 mg. The first two cohorts ...

Wegovy belongs to a group of drugs called glucagon-like peptide-1 ... (mg). You can then read on for more details. Wegovy comes as a liquid solution in a single-dose prefilled injection pen.

Zepbound is also available in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg per 0.5 mL doses in a single-dose pen (autoinjector ... the fourth quarter reached $1.91 billion, up from $175.8 ...

Note: This article describes typical dosages for Wegovy provided by the drug’s manufacturer. When taking Wegovy, always follow the dosage prescribed by your doctor. Each Wegovy pen delivers only ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in ... president of Novo Nordisk Inc., said in a statement Friday. GLP-1 drugs had been in shortage since 2022 due ...